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Law & Health Care Program 
Faculty, Alums and Students 
Immersed in Health Care Reform
The State of Maryland 
is one of the most active 
and engaged states in 
implementation of the Patient 
Protection and Affordable 
Care Act (ACA) and Law & 
Health Care Program faculty, 
alumni and students are right 
in the middle of these massive 
reforms. 
An active advocate of the 
state’s health care reform 
efforts in the area of mental 
health and substance use 
disorders is UM Carey Law’s 
Ellen Weber. Professor 
Weber teaches the Drug 
Policy and Public Health 
Strategies Clinic, which she 
created many years ago to address practices that inhibit the expansion of drug 
treatment in communities and discriminate against individuals with histories 
of drug dependence. Weber, who joined the faculty in 2002 after serving as 
the Senior Vice President for the Legal Action Center, has used the passage 
of the ACA as an opportunity to advocate for robust treatment benefits under 
the new law for individuals with mental health and substance use disorders. In 
2010, Weber was awarded a $350,000 grant from the Open Society Institute to 
ensure that the needs of this population were not ignored under the new reform 
payment and insurance models and that coordination and integration of addiction 
treatment and other health services would be a priority. 
To help carry out the work of the grant, Weber hired Paige Lescure. Having 
worked at the Maryland law firm Miles & Stockbridge, Ms. Lescure brought 20 
years’ experience in health care law to her new position as Senior Health Law & 
Policy Fellow at the School of Law. Together with their clinic students, Weber 
and Lescure have become a remarkably successful team. They have partnered 
with health services providers, advocates, public leaders and legislators in an 
effort to guide public health policy reform to ensure greater access to addiction 
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services in Maryland.
At a roundtable on health care reform held at the School of Law on March 1 
(see article on page 4), Professor Weber spoke about the work she and her team 
have done in the area of mental health and substance use disorder benefits under 
the ACA. She noted that, prior to the ACA, some states already had state-level 
mandates regarding coverage for mental health and substance use treatment 
but these laws varied dramatically across states in many areas, particularly 
in terms of cost sharing, limits on duration of care and the scope of covered 
services. Inadequate insurance coverage of these medical conditions throughout 
the nation’s history has led to a well-recognized denial of care for patients and 
a burden on the public health care system. Weber views the ACA as a long-
overdue mechanism to address these wide gaps in service. She hopes that 
implementation of the ACA will lead to improved patient outcomes and lessen 
the burden on the health care system by allowing for earlier diagnosis of mental 
health and substance use issues, creating a more robust network of providers 
to treat these conditions in the public and private health insurance markets, 
and creating greater availability of services. She also hopes it will end the 
unfair practice of cost-shifting from insurance carriers to individuals and health 
providers as well as cost-shifting from private to public insurers.
Under the ACA, Weber noted at the roundtable, services for mental health 
and substance use disorders are one of ten categories of services considered part 
of the Essential Health Benefits (EHB) package. The EHB package is a core 
package of health care services and benefits that must be covered by state plans 
starting in 2014. The baseline and default EHB package is that of a typical small 
employer-sponsored health plan. Professor Weber, Ms. Lescure and her clinical 
students worked very hard – and successfully – to ensure that Maryland adopted 
a very comprehensive benefit for treatment of mental health and substance use 
disorders in its benchmark plan. While the State adopted the small group plan 
as the benchmark plan for medical services, her team worked closely with state 
officials on the EHB package and helped ensure that Maryland substituted the 
behavioral health benefit from the Government Health Employees Association 
(GHEA) plan as the state’s benefit, as opposed to the default small group benefit. 
The GHEA behavioral health benefit is the most comprehensive among the 
ten benchmark plans and was incorporated based on the Clinic’s analysis that 
it would comply with the Mental Health Parity and Addiction Equity Act (the 
Parity Act). 
A main focus of Professor Weber’s work is at the intersection of the Parity 
Act and the ACA which, working in tandem, may mark the advent of greater 
and more robust treatment services. The Parity Act prohibits insurance carriers 
from imposing quantitative treatment limitations and cost sharing burdens on 
patients in a way that is different from those imposed on medical and surgical 
patients. The Parity Act covers every aspect of mental health and substance 
use disorder treatment including non-quantifiable treatment limitations such 
as medical management standards, medical necessity standards, network 
adequacy standards, and provider reimbursement. Weber is very encouraged that 
regulations from the Department of Health and Human Services require benefits 
for treatment of mental health and substance use disorders under the ACA to be 
provided in compliance with the Parity Act. Weber’s team has worked to make 
sure that Maryland’s benchmark plan meets the requirements of the Parity Act. 
Professor Weber has also looked at whether other states are using the Parity 
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Act to create robust drug and mental health treatment 
benefits. Although little detail is yet available, she noted 
that many state plans still include the historic limitations 
that Weber and her clinic have long fought against, 
including limitations on duration of care and wholesale 
exclusion of certain benefits like non-hospital residential 
treatment. Some states’ EHB benchmark plans also 
require pre-authorization for treatment services, in clear 
contravention of Parity Act standards. To date, it is unclear 
whether state insurance departments will root out these 
inequities as they certify health plans to be offered in and 
outside the Exchange. 
In addition to working on Maryland’s EHB plan, 
Professor Weber’s clinic was closely involved with the 
development of the Maryland Health Progress Act, the 
third bill passed by the Maryland General Assembly to 
implement health care reform. Her students evaluated the 
legislation and helped ensure that it provided for continuity 
of care protections for consumers as they move between 
Medicaid and private insurance plans sold in the exchange. 
In addition to the clinic’s focus on coverage, Weber 
also spoke about her focus on the other legs of the health 
care system’s three-legged stool – quality and access. A 
significant issue that Professor Weber has worked on is 
network adequacy and ensuring that carriers have included 
in their networks sufficient providers to meet the needs of 
all patients. She is working to ensure that, under the new 
benefit package, drug treatment programs can provide and 
be reimbursed for outpatient services, as they currently are 
in the State’s Medicaid system. Weber and the clinic are 
encouraging regulators to allow for program reimbursement 
so that a broader range of drug treatment counselors may 
continue to provide services within the scope of their 
practice. This will ensure cost-effective care and wider 
availability of services for a historically underserved group 
of individuals.
Alumni and Students Working in Health Care Reform
Rebecca Gwilt ’10, Senior Consultant, ACA Exchanges and Medicaid Policy, CGI
I joined the Obama administration shortly after graduating in the fall of 2010, and worked for HHS on regulatory 
and operational policy under the Affordable Care Act (ACA). I spent nearly two years as part of a team at the 
Center for Consumer Information and Insurance Oversight (CCIIO) building the framework necessary for the 
implementation of Health Insurance Exchanges and the Medicaid expansion in 2014. I recently left to join the 
national health care team of a large company (CGI) which contracts with States and the federal government 
to build and provide IT and business solutions to effectuate the implementation of State-based and Federal 
Exchanges and the modernization of state Medicaid systems to prepare for the 2014 reforms. 
Caroline Farrell ’10, Attorney, U.S. Department of Health and Human Services Office of the General 
Counsel, Centers for Medicare & Medicaid Services Division 
The Centers for Medicare & Medicaid Services (CMS) has had a tremendous amount of responsibility for 
implementing ACA. As an attorney in the CMS Division of the HHS Office of the General Counsel, my primary 
focus has been providing CMS legal advice as it implements the ACA. CMS Division attorneys work regularly 
with other attorneys in the HHS Office of the General Counsel and across the federal government to resolve 
novel, complex, high-profile legal questions and challenges arising from implementation efforts, which involve 
developing national programs to improve individuals’ access to quality, affordable health care. 
Sheena Tomar ’12, Associate Director of Government and Regulatory Affairs, the University of Maryland 
Medical System
Health care reform is on the fast-track in Maryland and actually helped create my position as Associate Director 
of Government and Regulatory Affairs at the University of Maryland Medical System’s (UMMS) Corporate 
Office last year. In my position, I track legislation in the General Assembly related to implementation of ACA 
requirements in Maryland, such as the Maryland Health Progress Act, and analyze its impact on UMMS as 
well as assess the hospitals’ compliance with the new Federal and State regulations. With a movement toward 
patient-centered care and better outcomes, my focus is on identifying legislation that will facilitate access to care 
and improve quality of care. I also follow developments of the Maryland Health Benefit Exchange, assessing 
UMMS’s feasibility and potential partnerships in becoming a connector entity to help enroll individuals into 
healthcare insurance plans starting January 1, 2014.
(Cont’d on p. 12)
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L&HCP Hosts “Health Care Reform: The State of 
the States” Roundtable
On March 1, UM Carey Law held a roundtable on the 
practical challenges and uses that states are facing in their 
implementation of the Patient Protection and Affordable 
Care Act. The roundtable was organized by Law & Health 
Care Program (L&HCP) faculty members Diane Hoffmann 
and Ellen Weber and built on a similar panel Professor 
Weber hosted at the 2012 ASLME Health Law Professors 
Conference. Professor Weber and the students in her Drug 
Policy and Public Health Solutions Clinic have been deeply 
involved in Maryland’s health care reform efforts in the 
area of mental health and substance use disorders. (See 
article on page 1.)
The roundtable brought together experts from a variety 
of fields to drill down into the details of implementation. 
Welcoming remarks were presented by Diane Hoffmann, 
Professor of Law and Director of the Law & Health 
Care Program, followed by introductions by Dr. Joshua 
Sharfstein, Secretary, Maryland Department of Health and 
Mental Hygiene, and Sonya Schwartz, Project Director 
of State Refor(u)m, National Academy for State Health 
Policy. Schwartz noted that the phrase “2014 Is Now” is 
frequently heard among people who are working furiously 
to implement health care reform at the state level by the 
start dates set forth in PPACA. The roundtable stimulated 
a great deal of information sharing on key issues currently 
being tackled by the states and created a framework for 
future collaboration. 
Eight mini-sessions were held throughout the day, 
covering topics relating to implementation of health 
insurance exchanges and Medicaid expansion, and featured 
the following distinguished discussion leaders:
• Dr. Peter Bielenson – Founder, Evergreen Health 
Cooperative
• Patricia Boozang – Managing Director, Manatt 
Health Solutions
• Brietta Clark – Professor of Law, Loyola Law 
School, Los Angeles
• Leonardo Cuello – Director of Health Reform, 
National Health Law Program
• Cheryl Fish-Parcham – Deputy Director of Health 
Policy, Families USA
• Bradley Herring – Associate Professor and Director, 
PhD Program in Health Economics & Policy, Johns 
Hopkins Bloomberg School of Public Health
• John Jacobi – Director, Dorothea Dix Professor of 
Health Law and Policy, Seton Hall University School 
of Law
• Kevin Lucia – Research Professor and Project 
Director, Georgetown University Health Policy 
Institute
• Ann Marie Marciarille – Associate Professor of Law, 
University of Missouri-Kansas City School of Law
• Susan McNally - U.S. Office of Personnel 
Management
• Judith Solomon – Vice President for Health Policy, 
Center on Budget and Policy Priorities 
• Sallie Thieme Sanford – Assistant Professor of Law, 
University of Washington School of Law
• Sidney Watson – Professor of Law, Saint Louis 
University School of Law
• Elizabeth Weeks – Associate Professor of Law, 
University of Georgia School of Law
• Tim Westmoreland – Visiting Professor of Law, 
Georgetown University Law Center
An upcoming symposia edition of the L&HCP’s Journal 
of Health Care Law & Policy will be devoted to papers 
developed from talks presented at the roundtable. 
The State of the States roundtable was supported with 
funding provided by the Rueben Shiling Mental Health 
Law Fund. Sonya Schwartz’s detailed overview of health 
care reform at the state level and a video of the roundtable 
are available at this link: http://www.law.umaryland.edu/
faculty/conferences/detail.html?conf=125.
(from l to r:) Dr. Joshua Sharfstein, Professor Diane  
Hoffmann, Professor Ellen Weber, and Paige Lescure
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Professor Amanda Pustilnik Works at the  
Intersection of Chronic Pain and the Law
L&HCP Professor Amanda Pustilnik is studying 
how chronic pain in treated in the law from two related 
perspectives -- disability and evidence. Pustilnik is 
currently working on an article that will be the follow-up 
to the article that she published last year titled “Pain as 
Fact and Heuristic: How Pain Neuromanaging Illuminates 
Moral Dimensions of Law,” (97 CorNeLL Law rev. 801). 
The new article takes the theoretical framework presented 
in the earlier piece and uses it to explore areas where 
emerging pain science, and particularly neuroimaging, 
can be used to improve and update specific areas of legal 
doctrine and practice. In the article she first presents the 
current science of chronic pain, building on extensive 
research, lab visits, and interviews with key researchers. 
She describes the contemporary scientific understanding 
of chronic pain as involving centralized neurological 
processes – not just the part of the body that hurts. She 
then contrasts the contemporary view of pain with the 
inadequate and outdated models of pain incorporated into 
the Social Security Disability regulations, the standards that 
federal judges apply to evaluate benefits decisions under 
those standards, to suggest reforms both in the regulations 
themselves and in the judicial practices of interpretation 
that have grown up around them. The paper then turns to 
the implications of contemporary pain science for evidence 
law, looking at both the narrative and the black-letter 
aspects of evidence. 
On the narrative aspects of evidence theory, the Pustilnik 
paper contends that courts often exclude and mis-evaluate 
relevant evidence because such evidence does not comport 
with the gate-keepers’ normative or narrative expectations 
of what chronic pain looks like and what actually causes 
it. Drawing on the literature on narrative in evidence 
law, and prior challenges to dominant narratives (like 
what the “good victim” looks like), she argues that long-
held psychosomatic assumptions about pain sufferers 
as malingerers or hysterics need to be challenged in and 
out of court. She then turns to black letter evidence law 
applications of new pain science. The paper presents a 
framework for analyzing when pain neuroimaging evidence 
ought to be admitted under the Daubert and Frye standards 
and when it ought to be excluded as either insufficiently 
reliable or insufficiently relevant.
The concepts discussed in this article will form the basis 
of a conference Professor Pustilnik is planning on pain 
and the law with David Semiowicz, a neuroscientist who 
is based in the UM School of Dentistry. Pustilnik and 
Semiowicz plan to convene an interdisciplinary group of 
primary neuroscience researchers, legal scholars, and legal 
practitioners (particularly judges and policy makers) to start 
a dialogue on, and come up with some set of best practices 
around, using pain neuroimaging to reform legal doctrines 
related to chronic pain.
Professor Amanda Pustilnik
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L&HCP and Student Health Law Organization 
Host Conference on FDASIA
The Law & Health Care Program and Student Health 
Law Organization, in conjunction with the University of 
Maryland School of Pharmacy’s Center for Drugs and 
Public Policy and Arnold & Porter LLP, hosted a well-
attended day-long conference in D.C., entitled “Emerging 
Issues in Food and Drug Law: Implementation of 
FDASIA,” on Wednesday, April 17th. The Food and Drug 
Administration Safety and Innovation Act (FDASIA), was 
signed into law by President Obama on July 9, 2012. 
While the Act is most known for reauthorization of 
user fees for brand pharmaceuticals and the addition 
of a user fee program for generics and biologics, the 
primary goal of Congress in passing the law was to 
provide FDA with new authorities to combat shortages 
of drug products in the United States and impose new 
requirements on manufacturers regarding early notification 
to FDA of issues that could lead to a potential shortage or 
disruption in supply of a product. Prior to FDASIA, only 
sole manufacturers of certain drug products for serious 
conditions were required to notify FDA of a discontinuance 
of those products. FDA received notifications from other 
manufacturers about potential shortages of other products 
on a voluntary basis. FDASIA provides FDA with enhanced 
authorities that:
• Broaden the scope of the early notification 
requirement by requiring all manufacturers 
of covered drugs to notify FDA of potential 
discontinuances. 
• Require manufacturers to report discontinuances to 
FDA regardless of whether they intend to discontinue 
the product permanently or are facing only a 
temporary interruption of supply. 
• Enable FDA to require, by regulation, mandatory 
reporting of shortages of biological products. The 
prior law excluded all biological products from the 
reporting requirements. 
• Require FDA to issue a non-compliance letter to 
manufacturers who fail to comply with the drug 
shortage notification requirements and to make 
the letter and the company’s response to the letter 
available to the public.
In addition to these provisions, the Act reauthorizes and 
amends several drug and medical device provisions that 
were scheduled to sunset and includes many new provisions 
that bolster medical product regulation, including a 
breakthrough therapies designation, making permanent 
two programs that encourage pediatric drug development, 
and increased patient participation in regulatory decision-
making. The law significantly changes the FDC Act and 
the PHS Act in several respects that will have considerable 
short- and long-term effects on the regulated industry. 
This timely conference was the brainchild of James 
Valentine, MHS, President of the law school’s Student 
Health Law Organization (SHLO) and an evening student 
at the law school. By day, James is a Program Analyst 
in FDA’s Office of Health and Constituent Affairs. With 
his law school, law firm, and FDA contacts, James and 
other members of SHLO organized an impressive panel of 
experts to discuss the critical components of this important 
new law. This is the second conference that the Law & 
Health care Program has sponsored for food and drug 
law attorneys. The first, in 2009, covered topics including 
biologics, federal preemption, REMS, and generic drugs.
The Keynote Speaker for the event was Leslie Kux, 
JD, Assistant Commissioner for Policy at the FDA. The 
following law school alumni who work in food and drug 
law served as panelists or moderators:
• Dom Cirincione, JD, MPP, Regulatory Counsel, 
Office of Medical Policy, Center for Drug Evaluation 
and Research, FDA
• David Clissold, JD, MA, Director, Hyman, Phelps & 
McNamara PC
• Brian Kehoe, JD, Congressional Affairs Specialist, 
Office of Legislation, FDA
• Jeremiah Kelly, JD, MPP, Attorney for Medical 
Product Development & Regulation, Office of the 
Staff Judge Advocate (JAG), U.S. Army Material 
Command (USAMRMC)
• Delia Stubbs, JD, Associate, Hyman, Phelps & 
McNamara PC
The conference website: http://www.cvent.com/events/
emerging-issues-in-food-and-drug-law-implementation-of-
fdasia/event-summary-3bb97324b1304384bbc5e5e8c919a
54e.aspx .
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Network for Public Health Law Continues 
 to Grow Under Leadership of Professor 
 Kathleen Hoke
The Network for Public Health Law, funded by the 
Robert Wood Johnson Foundation (RWJF), was launched 
in September 2010 to provide technical legal assistance to 
state and local public health officials, legislators and com-
munity groups working to secure evidence-based public 
health policy. Maryland Carey Law is home to the Net-
work’s Eastern Region, serving the Mid-Atlantic and New 
England states. When the original funding ended in March 
of 2013, RWJF agreed to extend the Network’s operations 
for another two years, awarding Maryland Carey Law near-
ly $1 million to continue the work in the Eastern Region.
L&HCP Professor Kathleen Hoke directs the Cen-
ter and integrates her Public Health Law Clinics into the 
Network’s operations. The Eastern Region also employs 
three attorneys who are alumni of the law school: Kerri 
Lowrey (Deputy Director); Cristina Meneses (Senior Staff 
Attorney); and Mathew Swinburne (Staff Attorney); as 
well as Program Manager, Megan Griest. Together the 
team produces issue briefs, webinars, blogs, and much 
more. Recently clinic students developed a 50-state survey 
of state law regulating the use of epinephrine in schools 
and prepared a companion issue brief suggesting that state 
and local governments could prevent harm to children by 
permitting schools to “stockpile” epi pens and train staff to 
use them in cases of suspected anaphylactic shock even in 
children not yet diagnosed with allergies. Because young 
children may have been exposed to a particular allergen—
i.e. a bee sting—until an unfortunate event occurs during 
the school day, access to an undesignated epi pen could 
prevent injury and death in schools with very little risk of 
harm. Students have also prepared briefs on issues as far 
reaching as teen driving and blogged about arsenic in rice, 
hospital liability for superbugs and electronic cigarettes.
This summer Network Eastern Region staff will present 
as a panel on childhood safety at the Safe States Alliance/
SAVIR Annual Conference; comment on denialism as an 
industry dynamic in public health at the annual American 
Society of Law, Medicine & Ethics’ Health Law Profes-
sors Conference; and host the full Network staff from all 
regions at the law school. In the coming year, Hoke and the 
Network hope to identify schools of law that are interested 
in exploring the creation of a public health law clinic to 
provide students the opportunity to practice public health 
law under the supervision of experienced faculty. This will 
not only benefit the students in searching for public health 
law jobs but it will expand the pool of lawyers educated 
and trained to assist in developing sound public health 
policy. 
UM Carey Law Participates in Interdisciplinary Insti-
tute for a Healthiest Maryland
UM Carey Law’s Legal Resource Center (LRC) for 
Maryland Public Health Law and Policy, formerly the 
LRC for Tobacco Regulation, Litigation and Advocacy, is 
participating in an interdisciplinary project under the aegis 
of the Institute for a Healthiest Maryland (IHM), a joint 
venture of the University of Maryland, Baltimore, and the 
Maryland Department of Health and Mental Hygiene. The 
LRC is participating in the IHM, along with representa-
tives from the UM Schools of Medicine, Pharmacy, Den-
tistry, and Nursing, as well as faculty from the University 
of Maryland, College Park; the University of Maryland, 
Baltimore County; and the Johns Hopkins Bloomberg 
School of Public Health. The campus-wide effort is funded 
by the CDC under the Community Transformation Grant 
Program. The main focus of the IHM is to reduce the public 
health burden in Maryland associated with tobacco use, 
obesity and hypertension. From supporting programs that 
allow pharmacists to provide more extensive counseling to 
patients with hypertension, to facilitating the adoption of 
smoke-free policies in multi-unit housing and helping local 
school boards increase physical activity and improve nutri-
tion in schools, the interdisciplinary team works collab-
oratively to identify evidence based, legally sound policies 
that will reduce the morbidity and mortality associated with 
tobacco use, obesity and hypertension in Maryland.
The LRC is directed by Professor Kathleen Hoke 
and supported by two attorney alumni, Managing Direc-
tor Rita Vera and Staff Attorney Will Tilburg. Students in 
Hoke’s Public Health Law Clinic assist with the LRC work, 
Cont’d on page 11
Professor Kathleen Hoke
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L&HCP’s Health Care Ethics Committee Network 
Hosts MOLST Training Session
Maryland health care providers who work with patients 
and families at the end-of-life assembled April 2nd at UM 
Carey Law for a day-long training session on how to use 
the new “medical orders for life-sustaining treatment” 
(MOLST) form for medical orders directing life-sustaining 
measures. The Maryland Health Care Ethics Committee 
Network (MHECN), an initiative of the Law & Health Care 
Program, sponsored the session. The Maryland MOLST 
form was proposed in 2011 and replaces the state’s DNR 
form. 
MOLST or POLST (“physician orders for life-sustaining 
treatment”) forms represent a significant paradigm 
change in advance care policy by standardizing provider 
communications through a plan of care in a portable way, 
rather than focusing solely on standardizing patients’ 
communications via advance directives. These forms 
require providers and patients or their surrogates to 
accomplish two core tasks:
• First, a health care professional initiates a discussion 
with a patient (or the patient’s authorized surrogate) 
about treatment options in light of the patient’s 
current condition. 
• Second, the patient’s preferences for end-of-life 
treatments are incorporated into medical orders, 
which are recorded on a highly visible, standardized 
form that is kept at the front of the medical record or 
with the patient if the patient lives in the community. 
MOLST and POLST forms record several 
treatment decisions common to seriously ill patients: 
cardiopulmonary resuscitation; the level of medical 
intervention desired in the event of an emergency (comfort 
only, limited treatment, or full treatment); and the use 
of artificial nutrition and hydration. As technology and 
treatment options change, the forms will also continue to 
evolve. Also unique to these forms is the fact that they 
are designed to transfer across treatment settings, so that 
the information in the form is readily available to medical 
personal, including EMTs, emergency physicians and 
nursing staff. MOLST and POLST Programs rely on a 
coordinated health care system to ensure preferences are 
honored throughout the course of a patient’s treatment. 
Maryland adopted a MOLST – rather than POLST – 
form because a nurse practitioner as well as a physician 
can sign the form. According to the Maryland MOLST 
Training Task Force which is made up of more than 
70 organizations, associations, facilities, providers, 
professionals, and consumers, the Maryland MOLST order 
form is designed to: 
• Consolidate important information into orders that 
are valid across the continuum of care; 
• Standardize definitions across end-of-life care forms; 
• Remind patients and providers of available treatment 
options; and 
• Increase the likelihood that a patient’s wishes 
regarding life-sustaining treatments are honored 
throughout the health care system 
The proposed regulations were recently updated by the 
Maryland Department of Health and Mental Hygiene to 
extend the date until July 1, 2013 for when assisted living 
programs, home health agencies, hospices, kidney dialysis 
centers, nursing homes, and hospitals (for certain patients) 
must complete MOLST forms for newly admitted patients. 
The workshop was designed for health care providers 
who interact with patients and families regarding end-
of-life decision making. Attendees learned how to use 
the Maryland MOLST form and their obligations and 
requirements under the MOLST regulations. Professor 
Diane Hoffmann, Director of the Law & Health Care 
Program, worked with MHECN Coordinator Dr. Anita 
Tarzian to organize the program. Dr. Patricia Tomsko Nay, 
Medical Director, Maryland Office of Health Care Quality, 
and Paul Ballard, Assistant Attorney General, led the 
training session.
Participants at L&HCP’s MOLST Training
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Faculty Highlights
Karen Rothenberg
• Professor Rothenberg’s article “ Finding Fault? 
Exploring Legal Duties to Return Incidental Findings 
in Genomic Research,” was accepted for publication by 
the GeorGetowN Law JourNaL. 
Diane Hoffmann
• Professor Hoffmann’s work was cited recently in 
the New York Times in an article by Laurie Edwards 
entitled “The Gender Gap in Pain.” The NYT article 
stated “The oft-cited study ‘The Girl Who Cried 
Pain: A Bias Against Women in the Treatment of 
Pain’ found that women were less likely to receive 
aggressive treatment when diagnosed and were more 
likely to have their pain characterized as ‘emotional,’ 
‘psychogenic’ and therefore ‘not real.’” Hoffmann’s 
article, co-authored by Dr. Anita Tarzian, appeared in 
the Journal of Law, Medicine & Ethics (29 (2001): 
13–27). The NYT article can be found at http://www.
nytimes.com/2013/03/17/opinion/sunday/women-and-
the-treatment-of-pain.html?pagewanted=all&_r=0. 
• Professor Hoffmann was appointed to the Maryland 
Stem Cell Research Commission as one of the 
Commission’s two bioethicists. The Commission is 
an independent unit within the Maryland Technology 
Development Corporation and establishes criteria, 
standards and requirements to ensure that stem cell 
research financed by the Maryland Stem Cell Research 
Fund complies with state law.
Leslie Henry
• Professor Leslie Henry’s article, “The Jurisprudence 
of Dignity,” 160 u. PeNN. L. rev. 169 (2011) was 
described as a “must read” in a very glowing review by 
Jonathan Simon, Adrian A. Kragen Professor of Law 
at Berkeley Law. You can find the full review at http://
crim.jotwell.com/dignity-is-coming/.
• Professor Leslie Henry has worked with several 
students (now recent alums) to help them publish 
several articles that were developed from seminar and 
independent study papers:
○  Max Siegel, “The Future of Family,” 23 Geo. 
MasoN u. C.r. L.J. 2 (2013)
○  Max Siegel, “Surviving Castle Rock: The Human 
Rights of Domestic Violence,” 18 Cardozo JourNaL 
of Law & GeNder 727 (2012)
○  Rebecca Spence, “Abandoning Women to their 
Rights: What Happens When Feminist Jurisprudence 
Ignores Birthing Rights,” 19 Cardozo JourNaL of 
Law & GeNder 101 (2012)
○  Mike Ulrich, “With Child, Without Rights?: 
Restoring an HIV+ Pregnant Woman’s Right to 
Refuse Medical Treatment,” 24 YaLe J.L. & feMiNisM 
303 (2012)
○  Mike Ulrich, “Researchers Without Borders?: 
Limiting Obligations of Ancillary Care Through 
the Rescue Model,” 3 HeaLtH Law & PubLiC PoLiCY 
foruM 28 (2011)
○  Mike Ulrich, “Resource Restraints: Rethinking 
Disclosure of Individual Genomic Findings,” MiCH. 
st. J. Med. & L. (forthcoming, 2013)
○  Christine White, “Let IVF Take its Course: 
Reconceiving Procreative Liberty for the 
Twenty-First Century,” 35 woMeN’s rts. L. reP. 
(forthcoming 2013–2014)
Michael Greenberger
• University of Maryland’s Center for Health and 
Homeland Security, directed by L&HCP faculty 
member Michael Greenberger, has recently begun 
developing two public health toolkits for the 
Association of State and Territorial Health Officials 
(ASTHO). These toolkits, which will be developed 
in collaboration with the Olson Group, will identify 
key legal barriers that arise in common public health 
situations.  The toolkits are designed to help public 
health officials nationwide improve their understanding 
of, and ability to navigate through, common issues 
encountered in public health emergency preparedness 
and response, such as shortages of medical resources 
and privacy of individuals’ personal health information. 
The toolkits, on the topics of altered standards of care 
and emergency drug shortages respectively, will be 
completed by late May 2013.
Ellen Weber
• Ellen Weber and students in her Drug Policy and 
Public Health Strategies clinic successfully advocated 
for a bill in Maryland that would create a program 
to make naloxone, a drug used to reverse an opioid 
overdose, more readily available to persons trained 
to identify opioid overdose symptoms and administer 
the medication.  The bills (SB 610/HB 890) that 
were approved by both houses of the Maryland 
General Assembly would create a program similar to 
programs in other states.  The CDC has documented 
that naloxone access programs save lives. In 2010, a 
CDC Harm Reduction Coalition study of 48 naloxone 
distribution programs in 15 states and the District of 
Columbia found that these programs led to 10,171 
opioid overdose reversals over a 14-year span, with 
a distribution of naloxone to an estimated 53,000 
individuals.
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Students Compete in
Health Law Regulatory & Compliance Competition
On February 16, 2013, the University of Maryland 
Francis King Carey School of Law held the 2nd Annual 
Health Law Regulatory and Compliance Competition. 
The Competition is designed to put students in the 
shoes of health law attorneys and regulators who handle 
complex regulatory and compliance questions. This year, 
thirteen teams from around the country participated in 
the competition. In addition to a home team from UM 
Carey Law, teams participated from Loyola Beazley, Saint 
Louis University, Temple, Seton Hall, Widener, American, 
University of Virginia, Hamline, Temple, Penn State, 
Washington University in St. Louis, and Southern Illinois 
University. Loyola’s team won first place honors with 
University of Virginia and Washington University coming 
in second and third place.  
During the competition, teams of three students analyzed 
a fact pattern using federal health regulations, rules, and 
agency documents, and presented a legal and policy 
solution and/or recommendations to a panel of regulatory 
and compliance attorneys. This year’s competition focused 
on the life sciences industry, food and drug law, and 
compliance with fraud and abuse laws related to companies 
that manufacture products regulated by the Food and Drug 
Administration (FDA).
The competition judges represented lawyers from 
some of the country’s most prominent health law firms 
including Arnold & Porter, Ober|Kaler, Epstein Becker 
Green, and Hyman, Phelps & McNamera, as well as FDA 
officials, health care executives, and the President of Bayer 
Healthcare LLC.  
The competition was generously supported by the law 
firms of Ober|Kaler and Epstein Becker & Green.
UM Carey Law Team (left to right):
3L John Glass, 3L Rebecca Hall, 1L Neha Patel, Virginia 
Rowthorn, Managing Director, Law & Health Care Pro-
gram, and Diane Hoffmann, Director, Law & Health Care 
Program.
Fourth Annual Health Law  
Service Trip to Mississippi
The Maryland Carey Service Corps Health Law Trip 
had another successful time in Mississippi in January. This 
is the fourth consecutive year that students from the law 
school have spent their final week of winter break working 
with the Mississippi Center for Justice (MCJ) on health-
related service projects. 
The group of nine Maryland students worked with 
MCJ on several projects involving the Affordable Care 
Act (ACA) and legal issues facing individuals with HIV/
AIDS. The group split their time between MCJ’s offices in 
Jackson and the Delta and, in their free time, made trips to 
the BB King Museum and the Catfish Museum. This year’s 
trip leaders were health law students Liz Rinehart and Vicki 
Chihos who had both been on the previous year’s trip. 
 The ACA team focused on Medicaid expansion, which 
is a hotly contested issue in Mississippi. In addition to 
meeting with stakeholder patients and clinicians, the 
team compiled data about the accessibility of Medicaid 
outstations (office where people can apply and re-apply for 
Medicaid) and created fact sheets regarding how Medicaid 
expansion would benefit different groups, such as children 
and those with pre-existing health conditions. MCJ will use 
By Abby Walk, Connie Lee, Liz Rinehart and Vicki Chihos
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the group’s work product to help educate legislators and the 
general public.
People living with HIV/AIDS in Mississippi face 
tremendous legal obstacles because of stigma and 
misperceptions about how the virus is spread. The law 
students put together a database of pro-bono legal providers 
in the state, developed a fair housing training program, and 
created legislative fact sheets on the benefits that Medicaid 
expansion would provide to people living with HIV/AIDS. 
The team also met with community advocates while in the 
Delta and took a tour of Taborian Hospital in the town of 
Mound Bayou. This historic hospital was the first hospital 
in the South to treat African American patients and was 
being renovated and reopened as an urgent care center. The 
experience was memorable and the team felt lucky to be 
included in the celebration. 
The students participated in a community meeting in 
Humphreys County organized by MCJ to discuss access 
to health care. A photo of the Maryland team at the 
community meeting and a description of their service 
project appeared in the Belzoni Banner. 
Plans for next year’s Health Law week are already 
underway as the group looks forward to continuing the law 
school’s partnership with MCJ.
Student Honors and Activities
• George A. Neyarapally 2L, Pharm.D., M.P.H., 
published the paper “A Review of Recent Federal 
Legislative and Policy Initiatives to Enhance the 
Development and Evaluation of High Value Drugs 
in the United States,” 14 dePauL J. HeaLtH Care L. 
503 (2013).
• Abe Gitterman 3L has had a number of papers 
selected for honors and publications:
○  Runner up in the 2012 ABA Health Law 
Section Writing Competition for his paper 
“Executives Should Think Twice Before 
Accepting Pleas ‘Relating to Fraud’: The 
Expansion of Exclusion Under the Park 
Doctrine.” The paper will be published in an 
upcoming edition of The Health Lawyer.
○  “Manufacturing a Solution: How the U.S. Food 
and Drug Administration Can Ensure the Safety 
and Security of a Globalized Drug Supply Chain” 
won second place and a $1,000 prize in the Food 
and Drug Law Institute’s H. Thomas Austern 
Memorial Writing Competition and will be 
published in an upcoming issue of FDLI’s Food 
and Drug Law Journal.
○  “What is the Best Way for Manufacturers and 
Physicians to Apply Sunscreen to Avoid Being 
Burned by the Final Sunshine Act Regulations?”, 
3 food aNd druG PoLiCY foruM 1 (no. 4, 2013).
• Jane (Yevgeniya) Kalinina, PharmD/JD student, 
was named an Express Scripts Scholar, a prestigious 
$10,000 award to a PharmD student in a joint 
degree program. The Express Scripts Foundation 
created the award to support the efforts of academic 
pharmacy to educate students with diverse interests.
• James Valentine 3E, was instrumental in creating 
and launching the new FDA Patient Network 
Website as part of his job as a program analyst in 
FDA’s Office of Health and Constituent Affairs. The 
Website is an interactive tool for educating patients, 
patient advocates, and consumers about their 
medications—prescription and over-the-counter—
and medical devices. James appears in a video clip 
advertising the new website. 
• Hannah Levinson 3L spoke at the Health Care 
Compliance Association’s Compliance Institute 
on April 23 as part of a panel titled “The Future 
of Compliance: Where Law Students and New 
Attorneys Fit In.”
UM Carey Law Students During Winter Break Service Trip 
to Mississippi
tracking state and local legislation on the covered issues, 
identifying potential policy options to address tobacco use 
and obesity in Maryland and reaching out to relevant local 
officials to discuss policy options. 
Network for Public Health
Cont. from p. 7
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Alumni and Students Working in Health Care Reform (cont’d)
Josh Greenfield 3L, Extern at CMS Center for Consumer Information and Consumer Oversight
Interning at the Centers for Medicare and Medicaid Services (CMS), has allowed me to appreciate the many 
complexities of healthcare reform and the ACA. We have been working to ensuring that many privacy safeguards 
and other protection standards are met for those who apply for coverage through the marketplace. It is exciting 
to see the behind-the-scenes work going into the federally-facilitated and state-based exchanges and to be a part 
of this massive undertaking. Even amidst the sequester, many talented and dedicated individuals are working 
tirelessly to ensure that deadlines are met and the marketplace “go-live” date goes as smoothly as possible. 
Blair Inniss 3L, Extern at the Hilltop Institute (a health research organization at the University of 
Maryland Baltimore County)
At the Hilltop Institute, my supervisor and I worked for the Maryland Health Benefit Exchange. Everything 
I did was with the purpose of helping Maryland prepare for open enrollment on the Exchange, which will go 
live on October 1, 2013. Some of my projects included following bills that my supervisor and the Exchange 
staff wrote, tracking policy guidance from the federal government and making sure that nothing Maryland is 
doing contradicts federal guidance, and helping to write draft regulations. Through the internship, I was deeply 
entrenched with healthcare reform and saw first-hand what it takes to implement such a massive, sweeping 
reform. It was one of my greatest learning experiences in law school.
Ian Clark 2L, Student Attorney, Drug Policy and Public Health Strategies Clinic
As a Student Attorney for the Health Care Reform Team of the Drug Policy and Public Health Strategies 
Clinic, I reviewed and commented on amendments, interim policies, and regulations regarding the Maryland 
Health Progress Act of 2013 and Maryland Health Benefit Exchange Acts, focusing on substance use disorder 
benefits. Over the course of the year, I participated in the stakeholder committee process and communicated with 
healthcare advocacy groups on projects involving Continuity of Care, the Maryland Essential Health Benefit 
and Benchmark Plan, Provider Network Adequacy, and the Health Information Exchange. I now have a greater 
understanding of the administrative and legislative lawmaking processes, and am honored to have had the 
opportunity to affect policy change and to help guide Maryland’s implementation of the ACA.
